Therapeuticsmd Inc (TXMD)

$1.10 -0.01 (-0.90%)
Market Cap 12.85M
Revenue (ttm) 1.76M
Net Income (ttm) -2.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -123.86%
Debt to Equity Ratio 0.00
Volume 10,900
Avg Vol 44,148
Day's Range N/A - N/A
Shares Out 11.57M
Stochastic %K 0%
Beta 0.42
Analysts Strong Buy
Price Target $5.00

Company Profile

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 561 961 1900
Address:
951 Yamato Road, Suite 220, Boca Raton, United States
Bio_Invest101
Bio_Invest101 Aug. 4 at 7:56 PM
$TXMD Tang and Xoma have been very busy hunting down the small biotechs. Not sure what/when Rubric could let this whole ordeal go. https://www.fiercebiotech.com/biotech/xoma-goes-shopping-struggling-biotechs-picking-hillevax-and-lava Xoma shops for struggling biotechs, buying HilleVax and Lava
0 · Reply
Kobe2324
Kobe2324 Aug. 4 at 4:20 PM
$TXMD I could really use this transaction money, get it finished
1 · Reply
mwhite9869
mwhite9869 Jul. 31 at 11:17 PM
$TXMD someone do the math for me. If outstanding shares end up sold at $10, what would the existing share price be?
1 · Reply
YPOJOB
YPOJOB Jul. 30 at 10:30 PM
$TXMD When you know. You know. I think soon! Less than 2 weeks.
1 · Reply
MorenitaScorp
MorenitaScorp Jul. 30 at 2:28 PM
$TXMD ⌚️
0 · Reply
hiTHit
hiTHit Jul. 28 at 4:17 PM
$TXMD When the price dropped from $100 to $1, I called out to the price like this: "Stop, don't do it, don't, no,...come back to me". The price also said to me like this:" Come to me, you bastard".
2 · Reply
Timtheshark
Timtheshark Jul. 25 at 7:57 PM
$TXMD this is usually a bullish sign 🤞🚀
0 · Reply
jfer333
jfer333 Jul. 21 at 11:58 PM
$TXMD is staying the course. Cosette may need to deal directly with TXMD to clean up royalty claims & secure long-term rights to key assets. If Rubric (TXMD’s top holder) wants a clean exit, a 3-way deal (HoldCo, asset carve-out, etc.) is now more likely. This lawsuit might actually put TXMD at the center of the M&A table.
1 · Reply
jfer333
jfer333 Jul. 21 at 11:57 PM
$TXMD court filing update today: Mayne filed a motion asking the court to pause the lawsuit and send the $11.5M dispute to a third-party accountant (BDO) based on a clause in their original agreement. TXMD hit back, saying the clause doesn’t apply here — this isn’t a working capital issue, it’s a breach of contract. Plus, they say Mayne waived that right by negotiating for months. Also, one of Mayne’s lawyers withdrew, but they’re still fully represented. Judge will now decide if the case moves forward or gets paused. 👀⚖️
0 · Reply
Jamesr00
Jamesr00 Jul. 18 at 5:04 PM
$TXMD i don’t know joe
0 · Reply
Latest News on TXMD
TherapeuticsMD Announces First Quarter 2025 Financial Results

May 13, 2025, 4:05 PM EDT - 2 months ago

TherapeuticsMD Announces First Quarter 2025 Financial Results

TherapeuticsMD Announces Full Year 2024 Financial Results

Mar 27, 2025, 4:05 PM EDT - 4 months ago

TherapeuticsMD Announces Full Year 2024 Financial Results

TherapeuticsMD Announces Third Quarter 2024 Financial Results

Nov 12, 2024, 4:05 PM EST - 9 months ago

TherapeuticsMD Announces Third Quarter 2024 Financial Results

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying

Aug 26, 2024, 7:36 AM EDT - 1 year ago

TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying

TherapeuticsMD Announces Second Quarter 2024 Financial Results

Aug 12, 2024, 4:05 PM EDT - 1 year ago

TherapeuticsMD Announces Second Quarter 2024 Financial Results

TherapeuticsMD Announces First Quarter 2024 Financial Results

May 10, 2024, 4:05 PM EDT - 1 year ago

TherapeuticsMD Announces First Quarter 2024 Financial Results

TherapeuticsMD Announces Full Year 2023 Financial Results

Mar 29, 2024, 4:00 PM EDT - 1 year ago

TherapeuticsMD Announces Full Year 2023 Financial Results

TherapeuticsMD Announces Third Quarter 2023 Financial Results

Nov 14, 2023, 4:05 PM EST - 1 year ago

TherapeuticsMD Announces Third Quarter 2023 Financial Results

TherapeuticsMD Announces Second Quarter 2023 Financial Results

Aug 14, 2023, 6:50 AM EDT - 2 years ago

TherapeuticsMD Announces Second Quarter 2023 Financial Results

TherapeuticsMD: From Fallen And Forgotten To Cash Cow

May 23, 2023, 9:00 AM EDT - 2 years ago

TherapeuticsMD: From Fallen And Forgotten To Cash Cow

TherapeuticsMD Announces First Quarter 2023 Financial Results

May 15, 2023, 4:05 PM EDT - 2 years ago

TherapeuticsMD Announces First Quarter 2023 Financial Results

TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

Apr 7, 2023, 4:01 PM EDT - 2 years ago

TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition

TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

Jan 3, 2023, 6:50 AM EST - 2 years ago

TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

Dec 4, 2022, 6:00 PM EST - 2 years ago

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

TherapeuticsMD Announces Third Quarter 2022 Financial Results

Nov 14, 2022, 4:05 PM EST - 2 years ago

TherapeuticsMD Announces Third Quarter 2022 Financial Results

TherapeuticsMD Announces Additional $7 Million Private Placement

Oct 31, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Additional $7 Million Private Placement

TherapeuticsMD Announces $7 Million Private Placement

Oct 3, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces $7 Million Private Placement

TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers

Sep 12, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q2 2022 Results - Earnings Call Transcript

Aug 15, 2022, 9:46 AM EDT - 3 years ago

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q2 2022 Results - Earnings Call Transcript

TherapeuticsMD Announces Second Quarter 2022 Financial Results

Aug 15, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Second Quarter 2022 Financial Results

TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022

Aug 8, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022

TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital

Aug 1, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital

Why TherapeuticsMD Shares Are Sinking Today?

Jul 13, 2022, 9:59 AM EDT - 3 years ago

Why TherapeuticsMD Shares Are Sinking Today?

TherapeuticsMD's stock falls 41% after tender offer expires

Jul 13, 2022, 8:25 AM EDT - 3 years ago

TherapeuticsMD's stock falls 41% after tender offer expires

TherapeuticsMD Announces Expiration of Tender Offer

Jul 13, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Expiration of Tender Offer

EW Healthcare Partners Announces Extension of TherapeuticsMD Tender Offer

Jul 6, 2022, 6:09 AM EDT - 3 years ago

EW Healthcare Partners Announces Extension of TherapeuticsMD Tender Offer

5 Short Squeeze Candidates To Watch This Week: Revlon Tops The List, A SPAC Shifts To Second And More

Jun 21, 2022, 12:01 PM EDT - 3 years ago

5 Short Squeeze Candidates To Watch This Week: Revlon Tops The List, A SPAC Shifts To Second And More

WEBR

TherapeuticsMD: Privatization Deal Expected To Meet With Shareholder Pushback

Jun 16, 2022, 2:43 PM EDT - 3 years ago

TherapeuticsMD: Privatization Deal Expected To Meet With Shareholder Pushback

5 Short Squeeze Candidates To Watch This Week: TherapeuticsMD Tops List While This Arts And Crafts Retailer Joins The Leaderboard

Jun 13, 2022, 10:49 AM EDT - 3 years ago

5 Short Squeeze Candidates To Watch This Week: TherapeuticsMD Tops List While This Arts And Crafts Retailer Joins The Leaderboard

BEEM

EW Healthcare Partners Announces Commencement of the Tender Offer for All Outstanding Shares of TherapeuticsMD

Jun 6, 2022, 4:05 PM EDT - 3 years ago

EW Healthcare Partners Announces Commencement of the Tender Offer for All Outstanding Shares of TherapeuticsMD

THERAPEUTICSMD INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TherapeuticsMD, Inc. - TXMD

May 31, 2022, 7:34 PM EDT - 3 years ago

THERAPEUTICSMD INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TherapeuticsMD, Inc. - TXMD

Here is why TherapeuticsMD jumped 300%

May 31, 2022, 1:57 PM EDT - 3 years ago

Here is why TherapeuticsMD jumped 300%

Why TherapeuticsMD Stock Is Soaring Today

May 31, 2022, 10:12 AM EDT - 3 years ago

Why TherapeuticsMD Stock Is Soaring Today

TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD

May 31, 2022, 6:00 AM EDT - 3 years ago

TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD

Why TherapeuticsMD Shares Are Trading Higher Today

May 20, 2022, 10:54 AM EDT - 3 years ago

Why TherapeuticsMD Shares Are Trading Higher Today

TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®

May 20, 2022, 9:43 AM EDT - 3 years ago

TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA®

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q1 2022 Results - Earnings Call Transcript

May 16, 2022, 8:07 PM EDT - 3 years ago

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q1 2022 Results - Earnings Call Transcript

TherapeuticsMD Announces First Quarter 2022 Financial Results

May 16, 2022, 4:05 PM EDT - 3 years ago

TherapeuticsMD Announces First Quarter 2022 Financial Results

TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022

May 10, 2022, 4:05 PM EDT - 3 years ago

TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022

TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million

Apr 14, 2022, 4:15 PM EDT - 3 years ago

TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million

GDRX

TherapeuticsMD: Looking For A Potential Turnaround After Divesting VitaCare Business

Mar 14, 2022, 8:39 AM EDT - 3 years ago

TherapeuticsMD: Looking For A Potential Turnaround After Divesting VitaCare Business

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd On Q4 2021 Results - Earnings Call Transcript

Mar 10, 2022, 10:35 AM EST - 3 years ago

TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd On Q4 2021 Results - Earnings Call Transcript

TherapeuticsMD Announces Fourth Quarter 2021 Financial Results

Mar 10, 2022, 6:50 AM EST - 3 years ago

TherapeuticsMD Announces Fourth Quarter 2021 Financial Results

Why TherapeuticsMD Shares Are Soaring Today

Mar 7, 2022, 9:38 AM EST - 3 years ago

Why TherapeuticsMD Shares Are Soaring Today

TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal

Mar 7, 2022, 7:57 AM EST - 3 years ago

TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal

TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx

Mar 7, 2022, 7:40 AM EST - 3 years ago

TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx

GDRX

Bio_Invest101
Bio_Invest101 Aug. 4 at 7:56 PM
$TXMD Tang and Xoma have been very busy hunting down the small biotechs. Not sure what/when Rubric could let this whole ordeal go. https://www.fiercebiotech.com/biotech/xoma-goes-shopping-struggling-biotechs-picking-hillevax-and-lava Xoma shops for struggling biotechs, buying HilleVax and Lava
0 · Reply
Kobe2324
Kobe2324 Aug. 4 at 4:20 PM
$TXMD I could really use this transaction money, get it finished
1 · Reply
mwhite9869
mwhite9869 Jul. 31 at 11:17 PM
$TXMD someone do the math for me. If outstanding shares end up sold at $10, what would the existing share price be?
1 · Reply
YPOJOB
YPOJOB Jul. 30 at 10:30 PM
$TXMD When you know. You know. I think soon! Less than 2 weeks.
1 · Reply
MorenitaScorp
MorenitaScorp Jul. 30 at 2:28 PM
$TXMD ⌚️
0 · Reply
hiTHit
hiTHit Jul. 28 at 4:17 PM
$TXMD When the price dropped from $100 to $1, I called out to the price like this: "Stop, don't do it, don't, no,...come back to me". The price also said to me like this:" Come to me, you bastard".
2 · Reply
Timtheshark
Timtheshark Jul. 25 at 7:57 PM
$TXMD this is usually a bullish sign 🤞🚀
0 · Reply
jfer333
jfer333 Jul. 21 at 11:58 PM
$TXMD is staying the course. Cosette may need to deal directly with TXMD to clean up royalty claims & secure long-term rights to key assets. If Rubric (TXMD’s top holder) wants a clean exit, a 3-way deal (HoldCo, asset carve-out, etc.) is now more likely. This lawsuit might actually put TXMD at the center of the M&A table.
1 · Reply
jfer333
jfer333 Jul. 21 at 11:57 PM
$TXMD court filing update today: Mayne filed a motion asking the court to pause the lawsuit and send the $11.5M dispute to a third-party accountant (BDO) based on a clause in their original agreement. TXMD hit back, saying the clause doesn’t apply here — this isn’t a working capital issue, it’s a breach of contract. Plus, they say Mayne waived that right by negotiating for months. Also, one of Mayne’s lawyers withdrew, but they’re still fully represented. Judge will now decide if the case moves forward or gets paused. 👀⚖️
0 · Reply
Jamesr00
Jamesr00 Jul. 18 at 5:04 PM
$TXMD i don’t know joe
0 · Reply
hiTHit
hiTHit Jul. 18 at 4:52 PM
$TXMD This board is a great place for the unhappy. Instead of being unhappy alone on other boards, it is happy to be a part of the collective unhappiness here.
1 · Reply
Kobe2324
Kobe2324 Jul. 16 at 12:54 PM
$TXMD litigation is such a draining thing. Both financially and time wise, you would think the companies would want to get this wrapped up. But no, we will wait until September and then they’ll extend some bs and make it December.
0 · Reply
Mustbe9ice
Mustbe9ice Jul. 15 at 6:19 PM
$TXMD wow I just saw this..1 employee tho
0 · Reply
ekraus
ekraus Jul. 13 at 8:35 AM
$TXMD might be $1…but i am not a buyer even if i can buy it for current price ( in other words my brokerage will not let me buy stocks under a limit, not sure of amount )
2 · Reply
ekraus
ekraus Jul. 13 at 8:32 AM
$TXMD i reain a holder of zero shres here do not intend to buy without seeing continued improvement and price getts high enough so my brokerage would let me buy this i think limit is nothing under $5, but not sure
0 · Reply
ekraus
ekraus Jul. 13 at 4:08 AM
$TXMD news?
0 · Reply
ekraus
ekraus Jul. 13 at 4:07 AM
$TXMD Feeling really bad
0 · Reply
Bio_Invest101
Bio_Invest101 Jul. 11 at 11:59 AM
$TXMD Buyer remorse…Courts are hard to get favorable judgment …renegotiate is an easy way out … https://www.afr.com/markets/equity-markets/hedge-fund-bets-us-suitor-won-t-get-out-of-mayne-pharma-takeover-20250709-p5mdop MYX ASX: Harvest Lane bets PE suitor Cosette can’t get out of Mayne Pharma takeover deal https://www.afr.com/companies/healthcare-and-fitness/proxy-advisers-support-mayne-pharma-deal-as-suitor-tries-to-exit-20250605-p5m56i Mayne Pharma: Proxy advisers support deal as suitor Cosette tries to exit
1 · Reply
ekraus
ekraus Jul. 11 at 6:09 AM
$TXMD hmmmmm….hhhhmmmmm
0 · Reply
ekraus
ekraus Jul. 10 at 4:53 AM
$TXMD Might be a place for a very small position, buvt it is risky imo. do your own dd, but be careful
0 · Reply
ekraus
ekraus Jul. 8 at 12:38 PM
$TXMD Looks not good
0 · Reply
hiTHit
hiTHit Jul. 7 at 3:32 PM
$TXMD When I add up the IQs of everyone here, including mine, the result is 19. I can't understand why it is so low.
1 · Reply